Wolden S - Search Results

1

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.

Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Riaz N, et al. Among authors: wolden s. Am J Clin Oncol. 2016 Feb;39(1):27-31. doi: 10.1097/COC.0000000000000006. Am J Clin Oncol. 2016. PMID: 24401670 Free PMC article.

2

Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.

Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD Jr, Wiener ES, Qualman SJ, Donaldson SS. Wolden SL, et al. J Clin Oncol. 1999 Nov;17(11):3468-75. doi: 10.1200/JCO.1999.17.11.3468. J Clin Oncol. 1999. PMID: 10550144

3

Management of breast cancer after Hodgkin's disease.

Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. Wolden SL, et al. J Clin Oncol. 2000 Feb;18(4):765-72. doi: 10.1200/JCO.2000.18.4.765. J Clin Oncol. 2000. PMID: 10673517

4

Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer.

Wolden SL, Steinherz PG, Kraus DH, Zelefsky MJ, Pfister DG, Wollner N. Wolden SL, et al. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):859-64. doi: 10.1016/s0360-3016(99)00493-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705006

5

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP, Pfister DG. Wolden SL, et al. J Clin Oncol. 2001 Feb 15;19(4):1105-10. doi: 10.1200/JCO.2001.19.4.1105. J Clin Oncol. 2001. PMID: 11181675 Clinical Trial.

6

A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: where does it fit among available treatment options?

Pfister DG, Sherman EJ, Wolden SL. Pfister DG, et al. Among authors: wolden sl. Cancer Invest. 2001;19(2):217-8. doi: 10.1081/cnv-100000157. Cancer Invest. 2001. PMID: 11296625 No abstract available.

7

Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.

Kushner BH, Wolden S, LaQuaglia MP, Kramer K, Verbel D, Heller G, Cheung NK. Kushner BH, et al. Among authors: wolden s. J Clin Oncol. 2001 Jun 1;19(11):2821-8. doi: 10.1200/JCO.2001.19.11.2821. J Clin Oncol. 2001. PMID: 11387353 Clinical Trial.

8

A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

Pfister DG, McCaffrey J, Zahalsky AJ, Schwartz GK, Lis E, Gerald W, Huvos A, Shah J, Kraus D, Shaha A, Singh B, Wolden S, Zelefsky M, Palgi I. Pfister DG, et al. Among authors: wolden s. Invest New Drugs. 2002 Feb;20(1):123-7. doi: 10.1023/a:1014449309165. Invest New Drugs. 2002. PMID: 12003188 Clinical Trial.

9

Improved outcomes in patients with osteogenic sarcoma of the head and neck.

Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR, Boyle JO, Pfister D, Shah JP, Kraus DH. Patel SG, et al. Among authors: wolden s. Cancer. 2002 Oct 1;95(7):1495-503. doi: 10.1002/cncr.10849. Cancer. 2002. PMID: 12237918 Free article.

10

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

Wong RJ, Lin DT, Schöder H, Patel SG, Gonen M, Wolden S, Pfister DG, Shah JP, Larson SM, Kraus DH. Wong RJ, et al. Among authors: wolden s. J Clin Oncol. 2002 Oct 15;20(20):4199-208. doi: 10.1200/JCO.2002.02.590. J Clin Oncol. 2002. PMID: 12377963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters